{
    "2021-01-21": [
        [
            {
                "time": "2021-02-10",
                "original_text": "Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Merck",
                        "Heart Failure",
                        "Vericiguat",
                        "FDA Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "The Zacks Analyst Blog Highlights: Novartis, QUALCOMM, Accenture, MetLife and Electronic Arts",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Novartis",
                        "QUALCOMM",
                        "Accenture",
                        "MetLife",
                        "Electronic Arts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology",
                        "insurance",
                        "entertainment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}